1,182
Views
29
CrossRef citations to date
0
Altmetric
Research Paper

Incorporating immunizations into routine obstetric care to facilitate Health Care Practitioners in implementing maternal immunization recommendations

, &
Pages 1114-1121 | Received 27 Nov 2013, Accepted 17 Jan 2014, Published online: 07 Feb 2014

Abstract

Immunization against pertussis, influenza, and rubella reduces morbidity and mortality in pregnant women and their offspring. Health care professionals (HCPs) caring for women perinatally are uniquely placed to reduce maternal vaccine preventable diseases (VPDs). Despite guidelines recommending immunization during the perinatal period, maternal vaccine uptake remains low. This qualitative study explored the role of obstetricians, general practitioners, and midwives in maternal vaccine uptake. Semi-structured interviews (n = 15) were conducted with perinatal HCPs at a tertiary maternity hospital in South Australia. HCPs were asked to reflect on their knowledge, beliefs, and practice relating to immunization advice and vaccine provision. Interviews were transcribed and coded using thematic analysis. Data collection and analysis was an iterative process, with collection ceasing with theoretical saturation. Participants unanimously supported maternal vaccination as an effective way of reducing risk of disease in this vulnerable population, however only rubella immunity detection and immunization is embedded in routine care. Among these professionals, delegation of responsibility for maternal immunization was unclear and knowledge about maternal immunization was variable. Influenza and pertussis vaccine prevention measures were not included in standard pregnancy record documentation, information provision to patients was “ad hoc” and vaccinations not offered on-site. The key finding was that the incorporation of maternal vaccinations into standard care through a structured process is an important facilitator for immunization uptake. Incorporating vaccine preventable disease management measures into routine obstetric care including incorporation into the Pregnancy Record would facilitate HCPs in implementing recommendations. Rubella prevention provides a useful “template” for other vaccines.

Introduction

Pertussis, influenza, and rubella are vaccine preventable diseases with potentially severe consequences for newborn infantsCitation1-Citation3 and in the case of influenza, for pregnant women.Citation3,Citation4 Maternal vaccination is a recommended part of perinatal care to provide protection for both mother and infant.Citation1-Citation4 However, in Australia, perinatal maternal uptake of pertussis and influenza vaccines is low,Citation5-Citation8 and despite a universal childhood immunization program, pertussis control remains problematic with epidemics occurring every 3–4 y.Citation9 Infants <6 mo, too young to have completed the recommended immunization course, are most at risk:Citation1 over 2009–2011, at least 7 Australian infants died following pertussis.Citation10 The cocooning strategy provides indirect infant protection through targeted vaccination of adults in direct contact with the newbornCitation1,Citation11 and pertussis vaccination is now recommended in the third trimester of pregnancy in Australia,Citation9 and USA and publicly funded in UK and New Zealand.Citation12 Maternal morbidity and mortality during the H1N1 09 influenza pandemic re-focused attention on the vulnerability of pregnant women to influenza infection.Citation4 Influenza vaccination is the only vaccine recommended and provided free for pregnant women in Australia.Citation13 Rubella is now a rare disease in Australia.Citation2 However, travel and migration from countries with lower levels of rubella control and the severity of sequelae from rubella during pregnancy, mean current vaccination schedules should continue.Citation2

Uptake of pregnancy-related vaccines by Australian adults is poor. The 2009 Adult Vaccination Survey estimated that only 11.3% of adults had received a pertussis booster.Citation5 Results of a 2011 survey in South Australia found only 20.3% (n = 48/237) of pregnant women received influenza vaccination, 4% (n = 12/297) received pertussis booster during pregnancy planning and 11% (n = 30/272) postnatallyCitation6 with similar findings for influenza vaccination reported by Wiley et al.Citation7

Perinatal health care professionals (HCPs) are uniquely placed to provide appropriate maternal vaccinations.Citation14 Recommendation by HCPs of maternal vaccination has been shown to increase influenza vaccine uptake in pregnancy.Citation7,Citation14 However barriers to maternal uptake have been identified including: lack of HCP recommendation,Citation7,Citation8,Citation15 cost,Citation15,Citation16 HCPs knowledge,Citation14,Citation16,Citation17 lack of patient oriented information or misinformation,Citation7,Citation15,Citation18 inconsistent advice, vaccine access,Citation8 and lack of clarity with respect to responsibility for implementing vaccine strategies.Citation14,Citation15 Australian studies have investigated the roles of midwives, GPs, and nurses in postnatal, newborn, and childhood vaccine uptake. However in Australia maternity care is largely team based, involving obstetricians, general practitioners (GPs), and midwives. While 3 Australian studies have investigated the role of Australian midwives in maternal and newborn vaccine uptake,Citation19-Citation21 none have investigated the contribution of these 3 occupational groups in maternal vaccine uptake within this care model.

Midwives’ self- efficacy in administering vaccines was found to be the most important factor in implementing a postpartum pertussis vaccineCitation20 and the need to further investigate midwives role in infectious disease prevention has been identified.Citation19

To gain a greater understanding of this perinatal preventative health role, a qualitative investigation was taken to explore the current practice of HCPs regarding maternal vaccine uptake and the interaction of knowledge, attitudes, beliefs, and practice.

Results

Participants revealed a high degree of trust in vaccine approval processes in Australia. Participants provided one or more rationales for their support as follows: personal experience observing women with severe response to Influenza H1N1 infection; having personally experienced pertussis infection; support for vaccines recommended and endorsed by trusted authorities; the strength of the evidence supporting the safety of recommended vaccines; and potential impact of infection on the newborn child. Participants did not question the safety of vaccines recommended in the Australian immunization schedule; this included the (then potential) recommendation of pertussis booster during pregnancy. However, 2 midwives qualified their approval adding they would need to do their own research before feeling confident to recommend a new maternal vaccine. Participants were unanimously supportive of maternal vaccine provision as a preventive health measure but indicated that, in practice, influenza, and pertussis vaccination were not consistently recommended, information was not consistently distributed and access to these vaccines was not provided in the study setting. It was noteworthy that these barriers were not present for rubella prevention, because postnatal rubella was “part of routine care.” Sample quotes from the participants illustrating the emergent themes discussed below, are shown in .

Table 1. Examples of participant responses within key theme areas

Barriers to implementing vaccine recommendations

Poor definition of responsibility for Vaccine Preventable Disease (VPD) management

All participants accepted responsibility for vaccine management but understood it to be a team effort, each group having a different role with final responsibility for team care being at an organizational level. Several participants recommended centralization of responsibility for maternal immunization at an organizational or population level. There were differences across the professional groups in their implementation of vaccine management measures. While obstetricians were supportive of vaccinations as a preventive measure, 2 obstetricians indicated that their focus was high-risk pregnancy care and therefore they delegated “routine” preventive measures to junior doctors or midwives. GPs saw vaccination as part of their work outside of the hospital setting, but indicated that there were no mechanisms in place to provide vaccination within the hospital setting. Midwives saw their role as including the education of women about preventive health measures for both mother and baby. Postnatal midwives believed it was their responsibility to give neonatal Hepatitis B immunizations and provide parents with vaccine information for the baby. In addition, midwives indicated they followed up rubella titer results and provided MMR (measles, mumps, rubella) vaccination when needed, following set protocols which required an order by a medical officer. However, their role in other maternal vaccines was limited. All participants would refer women, in the study setting, to their GP for vaccination other than MMR.

Variable HCP knowledge

Participants’ knowledge of maternal vaccine recommendations varied across the vaccines and the professional groups. Influenza immunization recommendations during pregnancy were well known, excepting midwives working exclusively in postnatal settings. However some participant obstetricians were unsure of the safety of first trimester vaccination and vaccination timing in relation to gestation. Pertussis booster vaccine recommendations, particularly the strategy of cocooning, were less well known. All GPs and most obstetricians interviewed were aware of pertussis vaccine recommendations but most midwives and some obstetricians were not. In contrast to these gaps in knowledge, all participants were aware of MMR vaccine requirements, procedures to identify low rubella immunity and mechanisms ensuring women received MMR vaccine postnatally, if needed.

Inconsistency across the information resources

Significantly, the professional resources chosen by participants to source information lacked vaccination recommendations. The South Australian Perinatal Care Guidelines cited by several obstetricians, as a source for vaccination information, contained no vaccine recommendations. Similarly the hospital intranet, suggested by some participants as an information source, also had no links to current vaccine recommendations. The GP Shared Care guidelines (devised for GPs involved in shared care), included appropriate recommendations for rubella screening, and MMR and influenza vaccination, but not pertussis vaccination. The Australian Immunization Handbook in hard copy was not an integral part of clinic resources and was better known among participants as a source of childhood immunization information. GPs received immunization updates in their private practice from the South Australia Health Communicable Disease Branch but not in the hospital setting.

Absence of vaccine references in documentation

There was no entry point into documentation for influenza and pertussis vaccines in the study setting. Maternal vaccines were not included as a discussion point in the South Australian Pregnancy Record (SAPR).Citation22 In contrast the SAPR reminds health professionals to discuss breast feeding, conduct antenatal education, and complete a smoking assessment. In addition, immunization history is not part of the lengthy medical, psycho-social, surgical, and family history taken at a woman’s first antenatal visit. As a consequence, maternal influenza and pertussis vaccines are offered largely in response to requests by women. Participants observed that demand fluctuated in response to media coverage. In those cases where vaccination was recommended by participants, there was no mechanism for documenting the response or following up. Participants stated that education about influenza and pertussis booster vaccines is not routinely included in perinatal care. This may be a particular issue in the public clinic care model where a woman may see a different HCP each visit.

Inconsistent education provision for women

Brochures were available in self-help stands in the antenatal clinic however women were not routinely directed to these resources. A folder given to women at the first antenatal visit contained the SAPRCitation22 and written information on topics such as breast feeding, nutrition in pregnancy, oral health, and sudden infant death syndrome (SIDS). Further information and advertising was given to all women in “Bounty bags.”Citation23 Immunization brochures were not included in either resource. The first visit was not viewed as the ideal time to introduce vaccination information because of the overwhelming amount of information provided to the women at that time. Postnatally, vaccination information focused on the newborn except for potential postpartum rubella vaccination. Rubella titer is individually mentioned in the SAPR as part of the initial antenatal screening tests, including a discussion point for test results and a place for postnatal follow-up where low immunity is documented. One midwife volunteered that women rarely refuse or question this test.

Barriers to accessing immunizations

Participants indicated that in the study setting, pertussis and influenza vaccines were not offered to women before, during, or after pregnancy. There was no routine mechanism for women to receive a vaccination in hospital. At best women were referred to their GP. Some participants were concerned that referring patients elsewhere could discourage or delay vaccination and that it undermined the public health message. Some HCPs were concerned that cost and the process presented barriers to women accessing pertussis vaccine. Participants recognized that influenza and pertussis vaccines were not part of the routine system of care.

Being part of a structured or systematic process

In contrast to influenza and pertussis vaccine management, interventions for MMR immunity detection, follow-up, and the offer of postpartum vaccination, when necessary, were described by all participants across each occupational group as being part of systematic process that works. MMR screening and follow up is embedded in routine care and is considered part of a midwife’s role. Constant communication about a woman’s infectious disease status also assists MMR follow-up in the context of a team environment. Facilitators and barriers to management of MMR, pertussis, and influenza vaccines were identified in the study setting (). All the components required to ensure delivery of MMR vaccine were embedded in routine pregnancy care. In comparison many components were absent for influenza and pertussis booster vaccines.

Table 2. Vaccine components present in the study setting for rubella, influenza and pertussis booster vaccines

Discussion

Our findings concur with Schrag et al.Citation15 that barriers to maternal vaccine uptake are not pregnancy specific; in particular, we found all participants were supportive of maternal vaccination (antenatal and postnatal) as a preventive strategy. We found similar barriers present in our study setting to those outlined in the Background but significantly only for influenza and pertussis vaccines. In particular, there was no clearly defined strategy for perinatal maternal vaccination against influenza and pertussis within the hospital setting, no entry point into the system of care and immunization history was not routinely collected in the medical history. None of these barriers were present in MMR vaccine management. This leads us to conclude that the failure in implementation is primarily due to a failure to incorporate pertussis and influenza vaccines into routine practice. The response of 2 midwives, that they would need to research the supporting evidence before recommendation, is in line with Australian Competency Standards, which require midwives to act as advocates for their patients and to maintain evidence informed practice.Citation24

Halladay and Bero in their review of research into the implementation of evidence-based practice, grouped intervention strategies into 3 broad types: practitioner-provided, organizational, and system-wide.Citation25 To implement change to current vaccination practice, strategies at each level would be required.

Practitioner strategies

That obstetricians may regard vaccination as outside their responsibility, has been reported previously;Citation15 a position expressed by some of our participants. Currently responsibility for perinatal vaccinations, which are not part of routine care, lack clear definition, so by default rest with individual practitioners, or the women themselves. The different but complementary roles of the 3 professional groups providing perinatal care require clear definition for vaccine management and cross-disciplinary communication strategies. Embedding ultimate responsibility for perinatal vaccination at an organizational or population health level, as suggested by some participants, would clearly demonstrate the value of the vaccines to HCPs and support maternal vaccine delivery. In addition, vaccination recommendations in shared web-based resources, in conjunction with staff skill training, would improve HCP knowledge.

Organizational strategies

Embedding a vaccine in routine pregnancy care has been demonstrated to increase maternal vaccine uptake. Healy et al. revealed that when a maternal postpartum pertussis vaccination was embedded in routine practice—such as standing orders for vaccines—maternal vaccine uptake increased.Citation11 Our findings support this contention. Embedding MMR vaccination into routine care ensured implementation, and as such offers an effective template for other perinatal vaccine management (). Dedicated immunization staff may improve access without increasing perinatal HCP workload.

Maternal vaccination awareness could be increased by the inclusion of materials in the folder provided to each woman at the first appointment. Consideration could be given to state-wide distribution from a central distribution point. Information sheets could be developed for staff to use when seeking maternal consent for vaccination such as are used for MMR vaccination.

System wide strategies

The “template” for maternal influenza and pertussis vaccines would include: (1) protocols and documentation supporting vaccine delivery; (2) HCP training and role definition within the protocols (3) routine provision of information to patients, and (4) ready access to vaccination for women. Directives, protocols, standing orders, and “tick boxes” are essential documentation elements serving to communicate across the team of HCPs, reminding staff to attend to preventive interventions.

A National Woman Held Pregnancy Record (NWHPR) has been developed and can be used by individual Australian States to develop their own individual patient pregnancy record.Citation26 These records are “held” by pregnant women, taken to ante-natal appointments and are a continuous record of their pregnancy. In addition to rubella screening the NWHPR includes a checkbox for influenza but not pertussis vaccination.Citation26 Western Australia has recently adopted this record. Of all the Australian states, only Queensland’s record includes reminders for both influenza and pertussis vaccination.Citation27

Related to access is the provision of funded vaccines. Influenza vaccination for at-risk populations, including pregnant women, is funded by the Federal government. Pertussis booster funding is state based and while some Australian states had funded pertussis vaccination programmes during the recent epidemic, the South Australian (SA) government only provided funding for 3 mo in 2010. Women requesting a pertussis booster vaccine from their GP would need to fill and pay for a script at a pharmacy. In contrast, as an inpatient medication in a public hospital, MMR vaccine is provided free of charge to patients in the study setting.

Limitations

This study was conducted at only one hospital, although 6 participants practiced obstetric care in other settings concurrently or recently and were able to provide wider insights. However, absence of funding for maternal pertussis vaccine (except in New South Wales and the Northern Territory), inconsistent inclusions of both influenza and pertussis recommendations in pregnancy records of the States, and lack of pertussis vaccine recommendations in the NWHPR, suggest our findings could reflect current practice across Australia. In addition, current maternal vaccine provision in the 2 other main SA public maternity hospitals is patchy: one hospital routinely provides influenza vaccine in antenatal clinic but pertussis booster postpartum is not provided, and in the other influenza vaccine is not provided antenatally but pertussis booster may be offered to some private patients.

Conclusion

Strategies embedded into routine care to ensure rubella immunity detection and MMR vaccination during pregnancy, functioned well. Embedding influenza and pertussis booster vaccines into routine pregnancy care would remove the logistical barriers to implementation and provide the structures needed to ensure women are routinely offered these interventions. Our study suggests that the timing of vaccine provision, such that it falls during pregnancy, is not a barrier, in Australia, to HCP support for vaccination. These findings have implications for delivery of these vaccines internationally since similar barriers to those found in our study have been described in other studies. What has not been previously described is the link between successful delivery of maternal vaccines and embedding the vaccines in routine care. Australian MMR vaccine interventions provide a possible “template” on which to base other perinatal vaccine interventions and thereby ensure implementation of national and international recommendations for vaccination during pregnancy.

Methods

Setting and participants

A tertiary teaching hospital in Adelaide was chosen as the study setting as South Australia’s (SA) largest provider of maternity and obstetric services (24.6% births in 2008–9).Citation28 The study setting provided 4 models of private and public care () similar in scope to the other 2 large public hospitals, a mix of clientele by socio-economic status and access to a range of HCPs involved in perinatal care. This diversity makes the setting ideal for examining the reasons for low rates of maternal influenza and pertussis vaccination in SA.

Table 3. Description of models of care in the study setting and participants drawn from each model

Potential participants were identified from respondents to a general email and announcements at 2 midwifery education seminars (antenatal and postnatal) and through targeted recruiting. Data collection aimed to capture “programmatic variations and significant common patterns within that variation.”Citation29 To achieve this participants were purposively recruited, stratified by occupation (midwives, GPs, and obstetricians) and across models of care to provide a sample with maximum variability.Citation29

Participants (n = 15) were GPs (3), obstetricians (6), and midwives (6) () capturing perspectives from each professional group, and model of care; senior staff responsible for whole department functioning; and a balance of senior and junior obstetricians and midwives, experienced in public and private practice.

Data collection and analysis

Semi-structured interviews were conducted January–April 2012, digitally recorded and transcribed verbatim. The interviews utilized open-ended questioning to explore participants’ vaccine management practice, professional vaccine information sources safety concerns and attitudes and beliefs about vaccinations as well as barriers and facilitators to incorporating vaccine management into perinatal care. Data collection ceased when no new themes emerged from 3 sequential interviews. Words in square brackets in quoted excerpts have been inserted by the researchers for clarity and to ensure confidentiality is maintained and meaning retained.

NVivo 9 softwareCitation30 was used to facilitate coding. Iterative thematic analysis was undertaken to enable understanding of processes occurring, participants’ experiences and reasons for participant responses.Citation31 This process allowed the researchers to move between data collection and analysis as codes were interpreted and themes developed. After initial coding, codes were grouped under themes describing the facilitators and barriers to perinatal vaccine management. The roles of the 3 professional groups’ and team interactions in VPD management were analyzed and compared. Professional VPD information sources referred to by participants, and information brochures intended for parents, were examined for references to VPD prevention (post-natal and antenatal maternal vaccines). Alignment between documentation, guidelines, and practice as described in the interviews, was examined. The first author coded the all the data and a second researcher (JS) coded 3 interviews to ensure consistency in themes identified. Any differences between the 2 coding schemes were discussed and resolved with all researchers.

Research ethics approval was granted by the Children, Youth and Women’s Health Human Research Ethics Committee.

Abbreviations:
HCPs=

health care professionals

VPDs=

vaccine preventable diseases

GPs=

general practitioners

MMR=

measles, mumps and rubella

SA=

South Australia

SAPR=

South Australian Pregnancy Record

NWHPR=

National Woman Held Pregnancy Record

SIDS=

sudden infant death syndrome

Conflict of Interest Statement

We wish to draw the attention of the Editor to potential conflicts of interest held by the authors and to the financial contributions which supported this work. H.M. is an investigator on vaccine trials. Her institution has received funding for investigator-led research from vaccine manufacturers including GlaxoSmithKline and Novartis Vaccines and Diagnostics. H.M. has received travel support from Novartis Vaccines and Diagnostics and GlaxoSmithKline to present scientific data at international conferences. We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that the order of authors listed in the manuscript has been approved by all of us. We confirm that we have given due consideration to the protection of intellectual property associated with this work and that there are no impediments to publication, including the timing of publication, with respect to intellectual property. In so doing we confirm that we have followed the regulations of our institutions concerning intellectual property. We further confirm that any aspect of the work covered in this manuscript that has involved human patients has been conducted with the ethical approval of all relevant bodies and that such approvals are acknowledged within the manuscript. We understand that J.S. is the sole contact for the Editorial process (including Editorial Manager and direct communications with the office). She is responsible for communicating with the other authors about progress, submissions of revisions, and final approval of proofs. We confirm that we have provided a current, correct email address which is accessible by the Corresponding Author and which has been configured to accept email from Human Vaccines and Immunotherapeutics.

Funding Statement

This study was partly funded by Immunization Branch, SA Health.

Acknowledgments

We would like to thank the obstetricians, GPs, and midwives who gave their time to participate in this study. We acknowledge the funding support for the project from SA Health. We would also like to thank Natalie Thomas, Anne Webster, Susan Lee, and Nino Marciano for assistance with study processes and Dr Joanne Collins for comment on initial drafts. Preliminary findings were presented by HW at the Public Health Association of Australia’s National Immunization Conference in Darwin in June 2012. Conference attendance was sponsored by Pfizer Australia. Helen Marshall acknowledges support from the National Health and Medical Research Council of Australia: Career Development Fellowship (1016272). Jackie Street acknowledges support from the National Health and Medical Research Council of Australia: Capacity Building Grant (565501).

10.4161/hv.27893

References

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.